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Human embryonic stem cells (hESCs) are derived
from the inner cell mass of the blastocyst. Despite
sharing the common property of pluripotency,
hESCs are notably distinct from epiblast cells of the
preimplantation blastocyst. Here we use a combina-
tion of three small-molecule inhibitors to sustain
hESCs in a LIF signaling-dependent hESC state (3iL
hESCs) with elevated expression of NANOG and
epiblast-enriched genes such as KLF4, DPPA3, and
TBX3. Genome-wide transcriptome analysis con-
firms that the expression signature of 3iL hESCs
shares similarities with native preimplantation
epiblast cells. We also show that 3iL hESCs have
a distinct epigenetic landscape, characterized by
derepression of preimplantation epiblast genes. Us-
ing genome-wide binding profiles of NANOG and
OCT4, we identify enhancers that contribute to rewir-
ing of the regulatory circuitry. In summary, our study
identifies a distinct hESC state with defined regulato-
ry circuitry that will facilitate future analysis of human
preimplantation embryogenesis and pluripotency.
INTRODUCTION
Embryonic stem cells (ESCs) are derived from the inner cell mass
(ICM) of the blastocyst (Evans and Kaufman, 1981; Martin, 1981;
Thomson et al., 1998) and are able to differentiate into the three
germ layers and potentially into all cells of the adult body. This
pluripotent property makes them invaluable in the field of regen-
erative medicine and as an important model for dissecting the
biological processes of human embryonic development. Even
though ESCs share the basic property of pluripotency with
epiblast cells of the ICM, differences between the two have
been observed (Nichols and Smith, 2012; Yan et al., 2013). A
comparison of the expression profiles of human preimplantation
blastocysts and hESCs highlighted that significant differencesCellexist between pluripotency in vivo and in vitro (Reijo Pera
et al., 2009; Vassena et al., 2011; Yan et al., 2013). In addition,
signaling pathways such as the LIF/STAT3 pathway, which
enhances blastocyst development (Dunglison et al., 1996), play
no reported role in the self-renewal of hESCs (Dahe´ron et al.,
2004; Humphrey et al., 2004). These differences are potentially
established in the process of hESC isolation (Yan et al., 2013).
Even though these differences are well recognized, no alterna-
tive hESCmodel systems have been described that more closely
resemble cells of the native preimplantation epiblast.
Previous studies have reported that a number of cell types
fulfill the criteria of pluripotency and that these distinct cells
correspond to different embryonic developmental stages (Brons
et al., 2007; Tesar et al., 2007). Interestingly, the different plurip-
otent cell states appear to be interconvertible. Conversion
between these cell states has been achieved by the overexpres-
sion of the pluripotency associated transcription factors
Nanog, Klf4, Nr5a2, and Stat3 (Silva et al., 2009; Guo et al.,
2009; Guo and Smith, 2010; Yang et al., 2010), as well as the
modulation of environmental signals provided by growth factors
or perturbation of signaling pathways (Bao et al., 2009; Zhou
et al., 2010). Factor-mediated conversion of different pluripotent
states has also been successfully applied to human cells
(Buecker et al., 2010; Hanna et al., 2010; Li et al., 2009; Wang
et al., 2011), illustrating the feasibility of isolating distinct human
pluripotent stem cell types. However, the requirement for the
continual expression of these transgenes limits the potential for
downstream application of these cells. Therefore, a transgene-
free method for generating hESCs that more closely resemble
the native pluripotent epiblast would be desirable. One approach
to achieve this goal is the application of small molecules, which
have been increasingly employed to manipulate cell fate in stem
cells and can facilitate the isolation of cell states that are chal-
lenging for growth factor and cytokine-only culture conditions
(Li et al., 2013; Zhang et al., 2012).
In this study, we use small molecules to target eight major
signaling pathways to screen for culture conditions that can
support a distinct human pluripotent stem cell state. We identify
a combination of three small molecules that, together with LIF
(3iL), support a distinct hESC state that more closely resembles
the pluripotent epiblast cells of preimplanation blastocysts thanStem Cell 13, 663–675, December 5, 2013 ª2013 Elsevier Inc. 663
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genes that are expressed in the epiblast such as NANOG,
DPPA3, KLF4, and TBX3. We also find that the epigenetic land-
scape of 3iL hESCs indicates a global derepression of genes
associated with pluripotent cells of human preimplantation
embryos. To gain insights into how the transition toward the
3iL state occurs, we mapped the binding profile of OCT4,
NANOG, and p300 by ChIP-Seq. This analysis highlighted
numerous regulatory sites near epiblast-specific genes that are
not detected in conventional hESCs, indicating the degree to
which 3iL hESCs have the potential to model transcriptional
regulation and epigenetics in early human embryogenesis.
RESULTS
A Combination of Small Molecules Induces a Unique
hESC State
To induce an alternative hESC state that is potentially closer to
the in vivo preimplantation epiblast state, we used 11 small
molecules that target eight signaling pathways to screen for
conditions that increase the expression of NANOG (Figure S1A
available online). NANOG serves as a deterministic marker in
the segregation of pluripotent epiblast from the hypoblast in
the inner cell mass of preimplantation embryos (Kimber et al.,
2008; Roode et al., 2012). The level of Nanog in mouse blasto-
cyst is decreased during implantation (Chambers et al., 2003),
suggesting that changing Nanog levels reflect different states
of pluripotency. The expression of NANOG is also enriched in
the human native preimplantation epiblast compared to hESCs
(Yan et al., 2013). We first investigated the influence of these
inhibitors individually. Although the cells treated with most of
the small molecules stained positive for hESC markers, they
did not exhibit a change in morphology or induce upregulation
of the NANOG transcript (Figures S1B and S1C). We therefore
proceeded to use combinations of thesemolecules (Figure S1D).
In contrast to the usage of individual molecules, treatment with
several combinations resulted in changes in both hESC
morphology and upregulation ofNANOG (Figure 1A, Figure S1E).
In particular, combinations 21, 22, 23, and 24 induced a 1.5- to
2.0-fold increase in NANOG transcripts. POU5F1 (OCT4) levels
remained largely unchanged in these combinations (Figure 1A),
suggesting that the cells are still pluripotent.
Next, we investigated whether chemical combinations 21 to
24 can stably sustain hESC self-renewal. However, we observed
a strong impairment in proliferation for three of the conditions,
such that few colonies survived after the first passage. Only
hESCs treated with combination 22 (PD03/BIO/DOR, herein
referred to as 3i) were able to form small, compact colonies on
mouse fibroblast feeders (Figure 1B). However, the number of
colonies decreased in each subsequent passage, indicating
that self-renewal is disrupted (Figures 1C and 1D). As the
morphology of these cells resembles that of mouse ESCs
(mESCs), we investigated whether activation of signaling path-
ways that promote the self-renewal of mESCs can improve cell
survival. LIF signaling is a key signaling pathway in the mainte-
nance of mESCs (Niwa et al., 1998), the ICM (Do et al., 2013),
and the conversion between mouse pluripotent states (Bao
et al., 2009; Yang et al., 2010). Strikingly, addition of LIF could
rescue the impaired self-renewal of 3i hESCs and enabled these664 Cell Stem Cell 13, 663–675, December 5, 2013 ª2013 Elsevier Incells to be stably propagated formore than 30 passages (Figures
1C and 1D). These 3i+LIF-treated hESCs (herein referred to as
3iL hESCs) form smaller andmore compact colonies than hESCs
cultured in TeSR1media (herein referred to hESCs) (Figure 1E). In
contrast to hESCs, 3iL hESCs can survive the passage as single
cells without the addition of ROCK inhibitor (Figure 1F). The
combinatorial use of the three inhibitors is important to maintain
the 3iL hESC state as the cells cannot be maintained when
individual chemicals are removed from the media (Figure S1G).
In summary, the application of three inhibitors and LIF enables
the efficient propagation of hESCs that are distinct from conven-
tional hESCs.
Active LIF signaling in 3iL hESCs
In contrast to conventional hESCs, which do not depend on LIF
signaling (Dahe´ron et al., 2004; Humphrey et al., 2004), LIF
appears to be essential for the self-renewal of 3iL hESCs. To fur-
ther investigate the roleof LIF in3iLhESCs,weusedaJak inhibitor
(inh) that targets the LIF signaling pathway (Hanna et al., 2010;
Yang et al., 2010). Treatment of 3iL hESCs with the Jak inh
induced a decrease in pluripotency marker expression and a
strong reduction in colony numbers (Figures 2A and 2B). Gene
expression of NANOG and LIF signaling-responsive genes KLF4
andSOCSwas reduced (Figure 2C). These results further indicate
that LIF signaling is required for the maintenance of 3iL hESCs.
LIF signaling can be induced in hESCs (Dahe´ron et al., 2004).
However, in contrast to 3iL hESCs, LIF is not essential for
hESC self-renewal. To investigate the cause of the difference in
LIF requirement, we compared LIF signaling activity in both cell
states. In hESCs, the transcript ofGP130, which is the coreceptor
essential for LIF activity (Ip et al., 1992), is poorly expressed rela-
tive to other components of the LIF signaling pathway (Figure 2D).
A short treatment of hESCs with 3i and stable culture of hESCs in
3iL both resulted in upregulation of GP130 transcript (Figures 2E
and 2F) and protein levels (Figure 2G), indicating that these cells
have become more sensitive to LIF signaling. Correspondingly,
the level of phosphorylated STAT3 was also significantly higher
in 3iL hESCs compared to hESCs that were cultured with LIF
alone (Figure 2H), suggesting that LIF signaling is more active
in 3iL hESCs. The expression levels of known STAT3 targets
SOCS3 and KLF4 were also increased in hESCs treated with
3i+LIF compared to LIF alone (Figure 2I). Interestingly, NANOG
expression levels increased with the addition of LIF in a
dosage-dependent manner under 3i treatment, suggesting that
NANOG might be a direct target of LIF signaling (Figure S2A).
These results indicate that while 3i treatment could not sustain
hESC self-renewal, it induces a hESC state that is highly respon-
sive to LIF signaling. In this scenario, elevated LIF signaling
becomes essential for maintenance of the pluripotent cell state.
We next investigatedwhether other signaling pathways impor-
tant in hESCs also play a role in 3iL hESCs. The FGF, PI3K, and
Activin signaling pathways have been reported to be important
for the maintenance of hESCs (Go¨ke et al., 2013; Singh et al.,
2012; Vallier et al., 2005). We treated 3iL hESCs with the respec-
tive small-molecule inhibitors of these three signaling pathways
and also of EGF signaling, which does not have a described
role in hESCs, as a negative control. The inhibition of FGF,
PI3K, and Activin signaling pathways resulted in the loss of
pluripotency markers after 10 days of treatment (Figures S2Bc.
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Figure 1. Small-Molecule Treatment of hESCs Induces a Novel LIF-Dependent hESC State
(A) Expression levels of pluripotency markers NANOG (top) and POU5F1 (bottom) for hESCs that were treated for 4 days with 24 different combinations of small
molecules 48 hr postseeding. Relative expression is obtained via normalization against the control samples treated with DMSO. All values are mean ± SD from
three independent experiments.
(B) Propagation of hESCs treated with chemical combinations 21 to 24 onmouse fibroblast feeders. Only hESCs treated with combination 22 form small compact
colonies. Scale bar represents 200 mm.
(C) Cells treated with combination 22 proliferate only in the presence of human LIF. Cells treated with combination 22 were continuously subcultured with or
without LIF. For each passage (P1–P3), cells were fixed upon confluency and stained with hESC-specific surfacemarker TRA-1-60. Scale bar represents 200 mm.
(D) Shown are the numbers of TRA-1-60 positive colonies for hESCs cultured in 3i, with or without LIF (P1-3). All values are mean ± SD from three independent
experiments.
(E) Morphology of 3iL hESCs and hESCs. Scale bar represents 200 mm.
(F) 3iL hESCs can be subcultured as single cells. 3iL hESCs and hESCs were subcultured as single cells into 96-well culture dishes at clonal density. hESCs
treated with and without ROCK inhibitor (1 mM Thiazovivin) served as control. The cells were maintained for 5 days, fixed, and stained for OCT4. All values are
mean ± SD from three independent experiments.
See also Figure S1.
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A Native Preimplantation Epiblast-like hESC Stateand S2C). This result suggests that other signaling pathways are
still required to act in conjunction with the LIF signaling pathway
to support the unique 3iL hESC state.
3iL hESCs Exhibit Hallmarks of Pluripotency
We next proceeded to characterize whether these 3iL hESCs are
indeed pluripotent. The cells stained positive for pluripotency
markers OCT4, NANOG, TRA-1-60, and TRA-1-81 (Figure 3A).
The transcript levels of the pluripotency markers remained
comparable between 3iL hESCs and untreated hESCs (Fig-
ure 3B). 3iL hESCs maintained a 2-fold higher level of NANOG
expression (Figure 3B), which was also reflected at the protein
level (Figure 3C). Interestingly, we observed an upregulation ofCellepiblast-enriched genes (Reijo Pera et al., 2009; Vassena et al.,
2011; Yan et al., 2013) including DPPA3, KLF4, and TBX3 in
3iL hESCs (Figure 3B). FACS analysis reveals that 3iL hESCs
clearly expressed OCT4 and have a marked increase in NANOG,
TRA-1-60, and TRA-1-81 levels (Figure 3D).
Next, we investigated whether the 3iL hESCs could differen-
tiate into all germ lineages. 3iL hESCs form largeembryoidbodies
that candifferentiate to cells of the extraembryonic lineage andall
three germ layers (Figure 3E). In vivo, 3iL hESCs also generated
tissues of all three germ layers when injected into immunodefi-
cient mice (Figure 3F). Interestingly, the 3iL hESCs generated
teratomas of a larger volume in a shorter time than hESCs (Fig-
ure 3G). Importantly, 3iL hESCs maintained a normal karyotypeStem Cell 13, 663–675, December 5, 2013 ª2013 Elsevier Inc. 665
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Figure 2. Self-Renewal of 3iL hESCs Is Dependent on LIF Signaling
(A) 3iL hESCs were treated with 0.6 mMof Jak inhibitor (inh). Control cells were treated with DMSO. The cells were fixed after 10 days of treatment and stained for
pluripotency markers NANOG, OCT4, and TRA-1-60.
(B) Number of TRA-1-60-positive colonies in 3iL hESCs with and without Jak inh. All values are means ± SD from three independent experiments.
(C) Expression of pluripotency genes and LIF signaling responsive genes in hESCs with and without Jak inh. All values are mean ± SD from three independent
experiments.
(D) Expression of LIF signaling components in hESCs. Shown are the average Ct values of STAT3, LIFR, GP130, and housekeeping gene GAPDH. The high Ct
value indicates that GP130 is poorly expressed in hESCs. All values are mean ± SD from three independent experiments.
(E) Induction ofGP130 expression when hESCs were treated with 3i. Relative expression levels were obtained via normalization against a control sample treated
with DMSO. All values are mean ± SD from three independent experiments.
(F) Relative expression level of GP130 in 3iL hESCs and hESCs. All values are mean ± SD from three independent experiments.
(G) Upregulation of GP130 protein in 3iL hESCs compared to hESCs. Antibody specific to GP130 was used to detect the presence of GP130 in whole cell extract
of 3iL hESCs and hESCs.
(H) 3iL hESCs show higher levels of phosphorylated STAT3 compared to LIF-treated hESCs. Whole-cell extracts of hESCs, hESCs cultured with 10 ng/ml of LIF,
and 3iL hESCs were used to determine the level of STAT3 phosphorylation in the respective culture condition. The GAPDH protein level served as a loading
control. Addition of LIF weakly activates STAT3 phosphorylation compared to the 3iL culture condition.
(I) Activation of STAT3 responsive genes SOCS3 andKLF4 in hESCs after treatment with 3i, 3iL, or LIF for 4 days. All values aremean ± SD from three independent
experiments.
See also Figure S2.
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results show that 3iL hESCs are indeed pluripotent. To confirm
that the 3iL hESC state is not unique to H1 hESC, we tested the
3i+LIF small-molecule combination on two other human hESC
lines, hES2andhES3 (FiguresS3A–S3L).Weobserved reproduc-
ible changes inmorphology, induction ofmarker expression, and
the ability to differentiate to all three germ layers in teratomas.
As both our TeSR1-cultured hES2 and hES3 hESCs showed
erosion of X inactivation, we were unable to examine the X-reac-
tivation in the 3iL culture condition. We next tested whether
the 3iL condition enables maintenance of human induced plurip-
otent stem cells (iPSCs). We treated reprogrammed cells with 3iL
conditions after 3 weeks of virus induction. While we did not666 Cell Stem Cell 13, 663–675, December 5, 2013 ª2013 Elsevier Inobserve an increase in total number of iPSC colonies (Fig-
ure S3M), we observed a significant improvement in virus
silencing in the colonies that did emerge (Figures S3N and
S3O), suggesting an increase in the number of bona fide iPSC
colonies (Chan et al., 2009). iPSC clones can also be stably
cultured in 3iL conditions (Figures S3P–S3R). These data confirm
that the induction of a distinct cell state by 3iL can be achieved
across different human pluripotent cell types.
The Transcriptome of 3iL hESCs Resembles Native
Preimplantation Epiblast
The above results indicate that 3iL hESCs are distinct from
hESCs. To characterize these differences, we compared thec.
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Figure 3. 3iL hESCs Are Pluripotent
(A) Staining of 3iL hESCs and hESCs for pluripotency markers NANOG and OCT4, and hESCs-specific cell-surface markers TRA-1-60 and TRA-1-81. Scale bar
represents 200 mm.
(B) Relative expression of pluripotency-associated genes and epiblast genes in hESCs and 3iL hESCs. All values are mean ± SD from three independent
experiments.
(C) Western blot analysis of protein levels for NANOG and OCT4 in hESCs and 3iL hESCs. Corresponding to the increase in NANOG gene expression level, the
NANOG protein level in 3iL hESCs is higher compared to hESCs.
(D) FACS analysis of pluripotency markers in 3iL hESCs and hESCs indicates that 3iL hESCs express higher levels of NANOG, TRA-1-60, and TRA-1-81.
(E) 3iL hESCs form embryoid bodies (EBs) in suspension culture and differentiate into the three germ layers and trophectoderm in vitro. Shown are 3iL hESC-
derived EBs cultured for 20 days in suspension (top left panel) and the adhesion and expansion of embryoid bodies plated onto gelatin plates (top right panel). 3iL
hESCs can differentiate into ectoderm (PAX6), definitive endoderm (SOX17), mesoderm (GATA4), and trophectoderm (p57Kip2). Scale bar represents 200 mm.
(F) 3iL hESCs form teratomas when injected into SCID mice. Shown are teratoma sections containing tissues that are representative of all three embryonic germ
layers. Scale bar represents 50 mm.
(G) 3iL hESCs form teratomas more efficiently than hESCs. Volume of teratoma formed by 3iL hESCs (left panel) and average time taken for the formation of the
teratoma (right panel). Shown are six replicates for each condition.
(H) 3iL hESCs exhibit a normal karyotype after 2 months in culture.
See also Figure S3.
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A Native Preimplantation Epiblast-like hESC Statetranscriptome of 3iL hESCs and hESCs using RNA-Seq. First we
identified genes that showed significant changes in expression
levels between 3iL hESCs and hESCs, further referred to as 3iL
hESC-specific (increased expression in 3iL hESCs) and hESC-
specific genes (decreased expression 3iL hESCs) (Table S1).
The 3iL-specific genes included NANOG, DPPA3, KLF4, and
TBX3 (Figure 4A), confirming our initial observations. To investi-
gate whether 3iL hESCs resemble in vivo pluripotent cells, weCellcompared the 3iL hESC expression data with single-cell RNA-
Seq data from human preimplantation embryos and primary
hESCs derived from blastocysts at passage 0 and 10 (Yan
et al., 2013). Strikingly, we found that 3iL hESC-specific genes
show significantly higher expression in preimplantation blasto-
cyst cells than hESC-specific genes (Figure 4B). In contrast,
hESC-specific genes show higher expression than 3iL hESC-
specific genes in primary hESC outgrowths from the blastocystStem Cell 13, 663–675, December 5, 2013 ª2013 Elsevier Inc. 667
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Figure 4. The Transcriptome of 3iL hESCs Resembles In Vivo Preimplantation Epiblast
(A) The normalized RNA-Seq read count of NANOG, KLF4, TBX3, DPPA3, and GAPDH in hESCs (blue) and 3iL hESCs (red). The black line shows the mean of
three replicates; the individual replicates are shown in light-blue and light-red, respectively (overlayed). Read counts were normalized by the number of mapped
reads for every replicate. Coordinates are for human genome version hg19.
(B) Comparison of expression of 3iL-specific genes with expression of hESC-specific genes in preimplantation embryos. Shown is the test statistic from an
unpaired t test; positive values indicate that 3iL-specific genes show higher expression than hESC-specific genes and vice versa for negative values. Significant
differences (multiple testing adjusted p value < 0.05) are marked with *. The data were normalized per sample and gene prior to testing.
(C) Heatmap showing single-cell gene expression from preimplantation blastocyst and hESCs for genes that are differentially expressed between 3iL hESCs and
hESCs. Clusteringwas done on this set of genes using hierarchical clustering. Genes are sorted by the fold change of average expression between blastocyst and
hESCs. Differentially expressed genes (3iL hESCs versus hESCs) are marked by black lines.
(legend continued on next page)
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A Native Preimplantation Epiblast-like hESC State(Figure 4B). Importantly, the set of 3iL hESC-specific and hESC-
specific genes is sufficient to discriminate hESCs from preim-
plantation blastocyst cells based on single-cell RNA-Seq data
(Figure 4C). The ICM of the profiled blastocyst (Yan et al.,
2013) consists of cells of the pluripotent epiblast (EPI) and cells
of the primitive endoderm (PE) (Roode et al., 2012). As we
were particularly interested in the epiblast cells of the blastocyst,
we assessed the expression of putative EPI-specific genes (Yan
et al., 2013) in 3iL hESCs. Genes that are expressed at a higher
level in EPI cells compared to hESCs (epiblast-specific genes)
are significantly enriched in 3iL hESCs (Figures 4D and 4E, Fig-
ures S4A–S4D). Increased expression of these epiblast-specific
genes in 3iL hESCs is further confirmed by quantitative PCR
(Figure 4F). Single-cell PCR data confirm that pluripotency genes
and epiblast genes are indeed coexpressed and not a result of
a heterogeneous cell population (Figure S4E). Thus, 3iL treat-
ment induces conversion of hESCs toward a cellular state that
more closely resembles pluripotent cells from the human preim-
plantation embryo.
Coexpression of GATA6 and NANOG in 3iL hESCs
One of the genes that is expressed in blastocyst (Yan et al., 2013)
and 3iL hESCs but not in conventional hESCs is GATA6
(Figure S4F). GATA6 has been reported to be able to replace
OCT4 during reprogramming (Shu et al., 2013) and is expressed
in early preimplantation embryos (Guo et al., 2010; Kimber et al.,
2008; Roode et al., 2012). As GATA6 is also implicated in primi-
tive endoderm (Kuijk et al., 2012) and mesoderm differentiation
(Abe et al., 2003), we wanted to exclude the possibility that
GATA6 expression is caused by spontaneous differentiation.
Examination of the expression of pluripotency-associated genes
indicated that these genes show similar expression levels in 3iL
hESCs and hESCs (Figure S4G). Validation by quantitative PCR
also confirms that differentiation-associated genes are not upre-
gulated in 3iL hESCs (Figure S4H). We further confirmed the
expression of GATA6 in the 3iL hESCs with quantitative PCR
and the protein levels with western blot analysis (Figures S4I
and S4J). Coimmunostaining of GATA6 and NANOG reveals
the coexpression of these twoproteins in 3iL hESCs (Figure S4K).
To further confirm this result, we performed flow cytometry anal-
ysis and found that, remarkably, more than 50%of the 3iL hESCs
express both NANOG and GATA6 compared to less than 5% in
the hESCs (Figure S4L). GATA6 is also coexpressed with OCT4
and TRA-1-60 (Figures S4M and S4N). These results indicate
that expression of GATA6 is not caused by differentiation or
loss of pluripotency, but rather reflects a specific property of
3iL hESCs. NANOG and GATA6 are coexpressed in cells within
the ICM of the blastocyst before the segregation of the pluripo-
tent epiblast from the hypoblast (Roode et al., 2012). Our results(D) Gene Set Enrichment Analysis (GSEA). Genes were ranked according to th
enrichment for genes which are differentially expressed in hESCs and human epib
enriched in the set of epiblast-specific genes (red line, Wilcoxon rank-sum test
ventional hESCs are enriched in the set of genes that show higher expression in
(E) Normalized expression of hESC-specific genes and 3iL hESC-specific genes
data), hESCs passage 0 (average from single cell data), and hESCs passage 10 (a
number of genes corresponds to genes that are differentially expressed in 3iL hE
(F) Real-time qPCR validation of epiblast-specific genes that are upregulated in 3iL
experiments.
See also Figure S4 and Table S1.
Cellsuggest that 3iL hESCs resemble these NANOG and GATA6
coexpressing cells. As such, 3iL hESCs could provide a model
to study the role of GATA6 and other early embryonic develop-
mental genes in pluripotency (Plusa et al., 2008; Roode et al.,
2012).
Derepression of Preimplantation Epiblast-Associated
Genes in 3iL hESCs
To investigate whether the gene expression profile of 3iL
hESCs is stabilized by a concomitant change in the epigenetic
landscape, we generated genome-wide profiles of histone
modifications associated with active (H3K27ac, H3K4me3) and
repressive (H3K27me3) chromatin. For every gene, we calcu-
lated a normalized fold change of the respective histone marks
between 3iL hESCs and hESCs. Indeed, we find that the change
in gene expression is accompanied by a global change in histone
modifications at relevant promoters (Figures 5A and 5B). Genes
that show increased expression in 3iL hESCs are significantly
enriched in the set of genes that show an increase of active
histone modifications H3K27ac (p value = 8.83e-263) and
H3K4me3 (p value = 2.38e-69), and a reduction in H3K27me3
(p value = 4.90e-92), which is a repressive mark usually associ-
ated with developmental genes (Figure 5B). Strikingly, when
we investigated promoters of genes which are differentially
expressed in the native preimplantation epiblast and in vitro
hESCs, we found that loss of H3K27me3 occurs at epiblast-
specific genes (Figure 5C). Thus, genes such as TBX3, KLF5,
ZNF600, and HOXB cluster that are silenced during derivation
of hESCs from the blastocyst show reactivation in 3iL hESCs
(Figure 5D, Figure S5). Together these data indicate that 3iL
hESCs reside in a distinct state that provides a unique model
for studying the epigenetics of preimplantation embryogenesis.
A Rewired Regulatory Circuitry in 3iL hESCs
The gene regulatory network that controls pluripotency has been
studied in ESCs (Boyer et al., 2005; Chen et al., 2008) and has
provided fundamental insights into the regulation of embryonic
stem cell identity. Our analyses of gene expression and
epigenetic modifications suggest that 3iL hESCs represent a
pluripotent state that is distinct from conventional hESCs. To
investigate whether the transcriptional regulatory network is
different in the two cell states, we generated genome-wide bind-
ing maps of the master pluripotency regulators NANOG and
OCT4, as well as the general enhancer binding protein P300.
For every binding site of OCT4, NANOG, and P300, we examined
differential binding between 3iL hESCs and conventional hESCs
to identify 3iL-specific and hESC-specific binding events.
Strikingly, we find that thousands of binding events change
between the two pluripotent states, indicating that the regulatorye fold change in expression between 3iL hESCs and hESCs. Shown is the
last (Yan et al., 2013). Genes that show increased expression in 3iL hESCs are
p value = 1.03e-48), whereas genes that show increased expression in con-
hESCs compared to human epiblast (green line, p value = 1.61e-20).
in 3iL hESCs, hESCs, human preimplantation epiblast (average from single cell
verage from single cell data). p values were calculated using a paired t test. The
SCs and hESCs and where expression is provided by (Yan et al., 2013).
hESCs compared to hESCs. All values are mean ± SD from three independent
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A Native Preimplantation Epiblast-like hESC Statenetwork indeed is rewired (Table S2, Table S3, Figure S6A). In
support of a rewired network, we find that transcription factor
differential binding is significantly associated with differential
expression of their target genes (Figure 6A).
As 3iL hESCs show epigenetic and transcriptional reactivation
of epiblast-specific genes that are silenced in conventional
hESCs, we investigated whether 3iL hESCs can be used to
identify enhancers that may be active in human preimplantation
development. We found that the increase in NANOG occupancy
at distal enhancers is significantly associated with upregulation
of epiblast-specific genes (Figure 6B) (Fisher’s test p value =
5.46e-13, Table S4). The genes that are expressed in the native
preimplantation epiblast and that show newor enhanced binding
sites in 3iL hESCs include NANOG, KLF4, DPPA3, KLF5,
DNMT3L, TBX3, ZNF600, and LAMB1 (Figures 6B and 6C, Fig-
ure S6B). Interestingly, we also detected STAT3 binding near
some of these genes (Table S5), suggesting that LIF signaling
may integrate with the core pluripotency network in 3iL cells
(Figures 6B and 6C).
DISCUSSION
In this study, we show that combinatorial treatment with three
small molecules successfully induces a distinct hESC state
that is different from conventionally cultured hESCs. These 3iL
hESCs require LIF to self-renew, and share an expression signa-
ture with pluripotent epiblast cells of the native human blasto-
cyst. Single-cell analysis of human preimplantation embryos
and hESCs has revealed significant differences between the
two (Yan et al., 2013). The 3iL hESC state that we have charac-
terized here narrows the gap between these in vivo and in vitro
pluripotent states (Figure 6D). The simlarity between 3iL hESCs
and native preimplantation epiblast cells provides a platform
for future studies in deciphering the molecular pathways that
specify pluripotency.
hESCs have been maintained in multiple chemically defined
conditions (Furue et al., 2008; Lu et al., 2006; Ludwig et al.,
2006; Vallier et al., 2005; Yao et al., 2006) using various external
signaling factors, including LIF (Gafni et al., 2013). The recently
reported LIF-dependent hESCs appear to be similar to naive
mESCs (Gafni et al., 2013). Through a different screening strat-
egy, we identified a distinct LIF-dependent pluripotent state
that harbors a native preimplantation epiblast gene expression
signature. Further work needs to be carried out to compare the
molecular and functional properties of naive hESC, 3iL hESC,Figure 5. The Epigenomic Landscape of 3iL hESCs
(A) GSEA plots showing enrichment of genes that show increase (red) or decrea
compared to hESCs. Genes are ordered by cuffdiff test statistic. Genes that show
increased H3K27ac (Wilcoxon rank-sum test p value = 8.83e-263), increased H
Genes that show decreased expression in 3iL hESCs are enriched in the set of ge
(p value = 3.38e-193), and increased H3K27me3 (p value = 1.44e-12).
(B) Fold change of normalized read counts for histone modifications at promoters
by cuffdiff test statistic and normalized per gene.
(C) Fold change of normalized read counts for histone modification at promoters
specific genes. Significance was estimated using the Wilcoxon rank-sum test.
(D) ChIP-Seq profiles of H3K4me3, H3K27ac, and H3K27me3 in 3iL hESCs and
H3K27me3 in 3iL hESCs. Blue bars mark regions with decreased H3K27ac and/o
number of mapped reads.
See also Figure S5.
Celland in vivo pluripotent states. We observed STAT3 binding sites
in the 3iL hESC transcriptional regulatory circuitry, suggesting
that LIF signaling may contribute to the 3iL hESC expression
signature. LIF signaling has been reported to enhance the forma-
tion of human blastocysts in vitro (Dunglison et al., 1996). How-
ever, how LIF signaling could play a role in pluripotent cells of the
blastocyst remains unknown. Hence, dissecting the role of LIF in
3iL hESCs could provide a better understanding of how LIF
signaling contributes to blastocyst development.
One of the hallmarks of 3iL hESCs is upregulation of a group
of genes that are expressed in early human embryogenesis,
some of which are thought to act as lineage specifiers. An
example is GATA6, which is expressed in the early ICM of both
mouse and human embryos (Guo et al., 2010; Roode et al.,
2012). Interestingly, GATA3, GATA4, and GATA6 were able to
replace OCT4 in reprogramming (Montserrat et al., 2013; Shu
et al., 2013), indicating a role of lineage specifiers in induced
pluripotency. Although the GATA6 locus is bound by OCT4,
NANOG, and STAT3, the role of GATA6 in the 3iL hESCs remains
to be elucidated. In the 3iL hESCs, GATA6 could be a component
of the pluripotency network through interaction with the core
pluripotency-associated transcription factors. Alternatively,
GATA6 could mark poised genes that will be induced during
lineage-specific differentiation. The 3iL hESCs might therefore
provide a tool for understanding the interplay between pluripo-
tency-associated transcription factors and lineage specifiers.
Although we showed that 3iL induces profound transcriptional
and epigenetic changes in hESCs, the mechanism for this
conversion is not completely understood. Our data demonstrate
that 3iL can strongly induce the expression of GP130, which
appears to be one of the rate-limiting factors for the activation
of LIF signaling in hESCs. It is also conceivable that 3iL, through
modulation of cellular signaling, can alter the binding of pluripo-
tency-associated transcription factors by creating new sites.
Indeed, we observed that many new or enhanced binding sites
occur in 3iL hESCs, and these are significantly associated with
a change in expression (Figures 6A–6C). Thus, a rewiring of the
regulatory network in response to treatment with 3i and LIF
appears to be involved in the cell state conversion.
As genome-scale analyses of regulatory networks require a
large number of cells they are generally not feasible for human
embryos. However, 3iL hESCs may provide a system for
studying gene regulation of pluripotency in the preimplantation
blastocyst. Using ChIP-seq profiling of chromatin marks and
transcription factor binding sites, we identified many previouslyse (green) of H3K4me3, H3K27ac, and H3K27me3 at promoters in 3iL hESCs
increased expression in 3iL hESCs are enriched in the set of genes that show
3K4me3 (p value = 2.4e-69), and decreased H3K27me3 (p value = 4.90e-92).
nes that show decreased H3K27ac (p value < 1.0e-300), decreased H3K4me3
of differentially expressed genes, estimated using DESeq2. Genes are ranked
(transcription start sites, TSS) of hESC passage 0-specific genes and epiblast-
hESCs. Pink bars mark regions with increased H3K27ac and/or decreased
r increased H3K27me3 in 3iL hESCs. Read counts were normalized by the total
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Figure 6. Remodeling of the Pluripotency Transcriptional Network in 3iL hESCs
(A) GSEA plots showing enrichment of genes that show increase (red) or decrease (green) of NANOG, OCT4, or p300 binding nearby. Genes are ordered by
cuffdiff test statistic. Genes that show increased expression in 3iL hESCs are enriched in the set of genes that show increased NANOG binding (Wilcoxon rank-
sum test p value = 3.97e-38), OCT4 binding (p value = 4.43e-11), and p300 binding (p value = 8.81e-24). Genes that show decreased expression in 3iL hESCs are
enriched in the set of genes that show decreased NANOG binding (p value = 7.16e-06) and decreased OCT4 binding (p value = 5.5e-08).
(legend continued on next page)
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human preimplantation blastocysts but repressed in hESCs,
demonstrating that 3iL hESCs provide insights into functions
that have been inaccessible prior to this study. In addition to
gene regulation, epigenetic characteristics also differ between
3iL hESCs and hESCs. For example, we observed a global
derepression of genes that are expressed in cells from human
preimplantation embryos and we find that several epigenetic
regulators such as DNMT3L are differentially expressed.
DNMT3L regulates DNA methylation, one of the key processes
during early embryonic development (Neri et al., 2013). 3iL
hESCs may serve as a model system to study these epigenetic
pathways and their roles in the regulation of pluripotency.
In conclusion, we report that treatment of hESCs with 3iL
induces a pluripotent state that is epigenetically, transcription-
ally, and morphologically distinct from conventional hESCs.
We demonstrate that a rewired regulatory circuitry in 3iL hESCs
supports a native preimplantation epiblast-like expression
signature. This more native state of 3iL hESCs presents new
opportunities. For example, it will be of great interest to use 3iL
culture to reset iPSCs into a more native epiblast-like state,
and to explore whether 3iL hESCs can lead to more efficient
lineage differentiation. Thus, the study of 3iL hESCs may further
revise and extend our understanding of pluripotency of human
cells.
EXPERIMENTAL PROCEDURES
Cell Culture
The hESC lines H1 (WA-01, passage 28), hES2 (ES-02, passage 79), and hES3
(ES-03, passage 97) were used for this study. For routine culture of hESCs in
TeSR1 (Stem Cell Technologies), cells were cultured feeder free on matrigel
(BD). Cell media was changed daily. The hESCs were subcultured with
1 mg/ml Dispase (Stem Cell Technologies) every 5–7 days. 3iL hESCs culture
medium contains 1 mM of PD0325901 (Sigma), 2 mM of BIO (Sigma), 2 mM of
Dorsomorphin (Sigma), and 10 ng/ml human LIF (Millipore) in TeSR1. 3iLmedia
are prepared fresh and stored at 4C for not more than 2 weeks. For treatment
with 3iL conditions, hESCs cultured in TeSR1 was treated with 3iL 48 hr post-
seeding. The cells are subsequently subcultured on mitomycin C inactivated
mouse fibroblast. Cells are dissociated to single cells using TrypLE (Life Tech-
nologies). 3iL medium is refreshed daily and cells are subcultured upon conflu-
ency. ROCK inhibitor Thiazovivin is added at a final concentration of 1 mM to
enhance cell survival for the first few passages. 3iL hESCs used in all the
experiments have been cultured for at least ten passages for adequate condi-
tioning to the new culture condition.
Small-Molecule Compounds Treatment
hESCs were dissociated with dispase and treatment starts 48 hr postseeding.
For single chemical and combinatorial chemical treatment, the small mole-
cules are used at the following final concentrations: 0.5 mMA83-01 (Stemgent),
2 mM BIO (Sigma), 3 mM CHIR99021 (Stemgent), 2 mM Dorsomorphin (Sigma),(B) Binding profiles of OCT4, NANOG and STAT3 in 3iL hESCs and hESCs. Pink
counts were normalized by the total number of mapped reads.
(C) A rewired transcriptional circuitry in 3iL hESCs. The 3iL induced circuitry (orang
the native epiblast, among others TBX3, DPPA3, and KLF5. The core pluripoten
SOX2 are still part of the new network, highlighting that the 3iL network is rewired
peak with significance score > 150), suggesting that the external signaling netw
epiblast signature in 3iL hESCs.
(D) 3iL supports a LIF-dependent hESC state thatmore closely resembles the nativ
or cell-type-specific factors. Full or dotted lines between circles denote the inte
gradient of coloration from red to orange represents the proximity of 3iL hESC a
See also Figure S6 and Tables S2, S3, S4, and S5.
Cell8 mM Forskolin (Stemgent), 2 mM IDE-1 (Stemgent), 0.5 mM PD153035
(Sigma), 1 mM PD173074 (Sigma), 1 mM PD0325901 (Sigma), 5 mM Pifithrin-a
(Sigma), and 1 mM RepSox (Sigma). All small molecules are reconstituted in
DMSO. For PI3K pathway inhibition, LY294002 (Sigma) was used at final con-
centration of 10 mM.
Quantitative PCR and RNA-Seq
For expression analysis, total RNA was extracted using the TRIzol reagent
(Invitrogen) and reverse transcribed using the SuperScript II Kit (Invitrogen).
Quantitative real-time PCR (qPCR) analysis was performed with the SYBR
Green Master Mix (KAPA) using the ABI PRISM 7900 sequence detection
system. RNA-Seq libraries were prepared using 4 mg of total RNA according
to manufacturer’s instructions (TruSeq RNA Sample Preparation Kit v2, Illu-
mina). Samples were multiplexed and sequenced single-read 76 bp (HiSeq
2000, Illumina).
Chromatin Immunoprecipitation
Chromatin immunoprecipitation was performed as previously described (Kar-
wacki-Neisius et al., 2013). ChIP-Seq library was prepared using the NEBNext
ChIP-Seq Library kit (NEB Biolabs) according to the manufacturer’s instruc-
tions and sequenced with the HiSeq 2000 system (Illumina).
Bioinformatics Analysis
RNA-Seq and ChIP-Seq data were mapped against hg19 (Langmead et al.,
2009; Trapnell et al., 2009), differential expression was estimated using cuffdiff
2.1.1 (Trapnell et al., 2013). The cuffdiff test statistic was used to rank genes for
the gene set enrichment analysis (Subramanian et al., 2005). Single-cell RNA-
Seq expression data from preimplantation human embryos were downloaded
(Yan et al., 2013), merged with 3iL hESC and hESC RNA-Seq data, and then
quantile normalized (Smyth, 2005). Expression values for every gene in every
sample were further divided by the sum of the gene’s expression. Peak calling
was done withMACS (1.4.0) (Zhang et al., 2008). The log-fold change for ChIP-
Seq data was calculated using DESeq2 (Anders and Huber, 2010). GSEA plots
for ChIP-Seq data were created using the top 1,000 loci with the strongest fold
change between 3iL hESCs and hESCs. Box plots were generated in R using
standard settings.
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